34: One-Stage Urethral Reconstruction for Stricture Recurrence after Urethral Stent Placement

2007 ◽  
Vol 177 (4S) ◽  
pp. 12-13
Author(s):  
Joel Gelman ◽  
Esequiel Rodriguez
Urology ◽  
2020 ◽  
Vol 146 ◽  
pp. 253-259 ◽  
Author(s):  
Christian P. Meyer ◽  
Jule Lamp ◽  
Malte W. Vetterlein ◽  
Armin Soave ◽  
Oliver Engel ◽  
...  

2014 ◽  
Vol 28 (5) ◽  
pp. 1384-1390 ◽  
Author(s):  
T.L. Hill ◽  
A.C. Berent ◽  
C.W. Weisse

Urology ◽  
2004 ◽  
Vol 64 (3) ◽  
pp. 582-584 ◽  
Author(s):  
J.Kellogg Parsons ◽  
E.James Wright

Author(s):  
Shaima Abulqasim ◽  
Mohammad Arabi ◽  
Khalid Almasar ◽  
Bayan AlBdah ◽  
Refaat Salman

AbstractThis article aimed to assess the safety and effectiveness of biodegradable stents in the management of benign biliary strictures. This is a retrospective observational study that included all adult patients who had biodegradable stent placement for a benign cause of biliary stricture between July 2016 and August 2019. Nineteen patients were included. Seventeen patients had liver transplant. One patient had hepaticojejunostomy due to primary sclerosing cholangitis and one patient had iatrogenic left main bile duct occlusion. Stents were successfully deployed in all 19 patients (technical success: 100%). Patency rate was 90% (17/19) at 6 months and 80% (12/15) at 12 months. Seven patients in the study had stricture recurrence and needed reintervention with mean time to reintervention of 418 days (range: 8–1,155 days). There was one major complication due to cholangitis and sepsis, which required a treatment course with piperacillin/tazobactam for 10 days. No procedure-related pancreatitis or deaths occurred. Biodegradable stents are a safe and effective treatment option for benign biliary strictures and can achieve long-term patency without the need for reinterventions.


2021 ◽  
Vol 10 (24) ◽  
pp. 5905
Author(s):  
Matthias D. Hofer ◽  
Lauren Folgosa Cooley ◽  
Ayman Elmasri ◽  
Francisco E. Martins

Background: Reconstructive approaches for distal urethral strictures range from simple meatotomy to utilizing grafts or flaps depending on the etiology, length and location. We describe a contemporary cohort of distal urethral strictures and report a surgical technique termed distal one-stage urethroplasty developed to address the majority of distal urethral strictures encountered. Methods: Thirty-four patients were included. The mean age was 56.7 years (range 15.7–84.9 years), the mean stricture length was 1.1 cm (0.5–1.5) and the mean follow-up was 42.5 months (28–61.3). Results: The vast majority of distal strictures (27/34 (79.4%)) were treated with our hybrid one-stage approach combining a distal urethral reconstruction with excision of the scar tissue without the need to use grafts or flaps. The average stricture length was 0.68 cm and average operative time was 24.43 min. Post-operative spraying was reported in a minority of patients (4/27 (14.8%)). The length of stricture and surgery were significantly longer in those 7/34 (20.6%) patients in whom grafts or flaps were used (2.88 cm and 154.8 min, respectively, p < 0.001 for both when compared to the hybrid one-stage approach). We noted 6/34 (17.6%) recurrences of distal urethral strictures, all of which were treated successfully with graft and flap repairs. Conclusions: The vast majority of distal urethral strictures are amenable to a distal one-stage urethroplasty, avoiding the use of grafts and/or flaps while achieving reasonable outcomes. This limited approach, at least initially, is associated with shorter operative time and time of catheter placement and avoids morbidity associated with graft or flap harvesting. Spraying of urine is seldomly encountered and comparable to other approaches addressing distal urethral strictures.


Sign in / Sign up

Export Citation Format

Share Document